Login / Signup
Guanghui Shen
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 1
Top Topics
Immune Response
Tyrosine Kinase
High Dose
Bioinformatics Analysis
Top Venues
Immunotherapy
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Xichen Zheng
,
Jiajie Kuai
,
Guanghui Shen
Low-dose metronomic gemcitabine pretreatments overcome the resistance of breast cancer to immune checkpoint therapy.
Immunotherapy
(2023)